GW Pharmaceuticals Stock
This Pot Stock Could Be Special Today, I'm taking a look at a special stock: GW Pharmaceuticals PLC (NASDAQ:GWPH). It’s no secret that retail investors love pot stocks. With companies in this booming industry often posting double-digit—in some cases, triple-digit—percentage year-over-year sales growth, a lot of people want…
Marijuana Industry Growth When people think of marijuana, they typically think of the classic rolled joint that has been a pop culture staple for decades. But when it comes to the marijuana industry, the growing popularity and legality of the drug has fueled an explosion in how one…
GWPH Stock Sees Gains as it Expands Into Europe Marijuana investors can be fickle at times. With marijuana legalization gaining traction around the globe, many forget where the first legal cannabis profits came from: medical marijuana. This is a very lucrative subsector that is continuing to grow, and…
GW Pharmaceuticals Financial Results The medical marijuana industry is sometimes overlooked now that recreational marijuana has entered the scene in a big way. GW Pharmaceuticals PLC (NASDAQ:GWPH) is proving why that is a mistake. This stock is up big following the release of GW Pharmaceuticals' financial results, and…
Marijuana News Today And there we have it. The marijuana news today sees "Epidiolex," the first-ever cannabis-derived medicine approved by the Food & Drug Administration (FDA), hit shelves across the U.S. today. This is a huge milestone not only for GW Pharmaceuticals PLC (NASDAQ:GWPH), the maker of the…
Marijuana News Today The marijuana news today represents another victory for pot stocks in the U.S. market as the United States Drug Enforcement Administration (DEA) has reclassified the first cannabis-derived medicine in the U.S. from a Schedule 1 drug to a Schedule 5, significantly reducing the restrictions on…
GW Pharmaceuticals Stock When we think of the legal marijuana industry, our minds often go to massive greenhouses or poorly chosen pun-named storefronts, but that discounts a whole subsection of the industry that is on the rise: medical cannabis. The development of medical cannabis, while perhaps not as…
Marijuana News Today The marijuana news today is heavy with good news. The first bit of positive news is that a young girl suffering from epilepsy is now "pharma-free" after switching to medical marijuana treatments. One of the most promising applications for medical marijuana is in the treatment…
Embedded Pattern Supports the Notion of a Higher GWPH Stock Price Just as I think the markets are ready to make a sustained move toward higher prices, a catalyst emerges to remind me that the current market is very turbulent. As a result, caution is still warranted. The…
Epidiolex Stock Prices Today marks a turning point in the legal marijuana market. The first ever FDA-approved cannabis drug, "Epidiolex," is going to be the trailblazer for cannabis-derived medicines in the United States. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) will supply the drug to the U.S. market via its subsidiary Greenwich…
Marijuana News Today The marijuana news today has another big win for medical marijuana stocks as Oklahoma voted to legalize medicinal cannabis. Not only that, but the state proposal is one of the most comprehensive and permissive medical marijuana bills to date. The deep red state of Oklahoma…
Marijuana News Today The marijuana news today is all about medical cannabis. And, more importantly to our readers, medical marijuana stocks. The biggest news is that we now have the first ever cannabis-derived prescription drug officially approved by the U.S. Food and Drug Administration (FDA). In addition to…
Marijuana News Today While the business headlines are still being dominated by the Canadian marijuana legalization date being set for October 17, the marijuana news today has another milestone worthy of note. The first ever cannabis prescription drug is up for approval by the U.S. Food and Drug…
GWPH Stock Forecast GW Pharmaceuticals PLC (NASDAQ:GWPH) got a dose of exactly the right kind of medicine when its "Epidiolex" drug received a positive internal briefing note from the U.S. Food and Drug Administration (FDA). Epidiolex is one of the company's biggest plays and really the only one…
GW Pharmaceuticals Stock Price In the world of pharmaceuticals, patents are one of the most critical aspects to a company's stock forecast. Being able to pass clinical trials and obtain patents can make or break a company's share value overnight. GW Pharmaceuticals PLC - ADR (NASDAQ:GWPH) is heavily invested…
Why GWPH Stock Is in a Downtrend With all the hype surrounding recreational marijuana legalization around the world, one aspect of the industry that tends to get left by the wayside is medical marijuana. While there are a great many companies making good money off of the medical…
